(PR-inside.com) CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce the formation of a dedicated AI team focused on enhancing the capabilities of the ABBIE (A Binding-based Integrase Enzyme) system and the design of novel guide RNAs and other RNA